Pharsight

1. List of Metrogel drug patents

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7348317	GALDERMA LABS LP	Aqueous compositions containing metronidazole	Feb, 2022 (1 year, 3 months ago)
US6881726	GALDERMA LABS LP	Aqueous compositions containing metronidazole	Feb, 2022 (1 year, 3 months ago)

Do you want to check out METROGEL patents from before 2022?

Market Authorisation Date: 30 June, 2005

Treatment: Once a day topical treatment of the inflammatory lesions of rosacea

Dosage: GEL;TOPICAL

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
0.01	21 Oct, 2008	1	22 Jul, 2011	21 Feb, 2022	Eligible

Strength	Dosage	Availability
1%	GEL;TOPICAL	Prescription

United States

European Union

Russia

Spain

Hong Kong

Austria

Denmark

Germany

China

Brazil

Canada

Argentina

Japan

Korea, Republic of

Cyprus

Portugal

Mexico

Australia

South Africa

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8877792	CHEMO RESEARCH SL	Compositions for increasing solubility of azole drug compounds that are poorly soluble in water	Feb, 2028 (4 years from now)
US7893097	CHEMO RESEARCH SL	Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water	Feb, 2028 (4 years from now)
US8658678	CHEMO RESEARCH SL	Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water	Jun, 2028 (5 years from now)
US8946276	CHEMO RESEARCH SL	High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis	Jun, 2032 (9 years from now)
US9198858	CHEMO RESEARCH SL	Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations	Jun, 2032 (9 years from now)
US10238634	CHEMO RESEARCH SL	Aqueous-based metronidazole gel formulations	Jun, 2032 (9 years from now)
US10596155	CHEMO RESEARCH SL	Aqueous-based metronidazole gel formulations	Jun, 2032 (9 years from now)

Do you want to check out NUVESSA patents from before 2022?

Market Authorisation Date: 24 March, 2014

Treatment: Treatment of bacterial vaginosis; Treatment of bacterial vaginosis with metronidazole gel

Dosage: GEL;VAGINAL

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
0.013	30 Mar, 2022	1		28 Jun, 2032

Strength	Dosage	Availability
1.3%	GEL;VAGINAL	Prescription